The ODYSSEY DM-DYSLIPIDEMIA trial: Confirming the benefits of alirocumab in diabetic mixed dyslipidemia

Paul Chan, Li Shao, Brian Tomlinson, Zhong Min Liu

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Article number477
JournalAnnals of Translational Medicine
Volume5
Issue number23
DOIs
Publication statusPublished - Dec 1 2017

ASJC Scopus subject areas

  • Medicine(all)

Cite this